# Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

> **NCT00996684** · PHASE2 · UNKNOWN · sponsor: **University of California, Los Angeles** · enrollment: 30 (estimated)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** Microplasmin
- **DRUG:** Placebo control

## Key facts

- **NCT ID:** NCT00996684
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00996684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00996684, "Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00996684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*